Literature DB >> 17223417

Risk-adjusted mortality analysis of percutaneous coronary interventions by American College of Cardiology/American Heart Association guidelines recommendations.

H Vernon Anderson1, Richard E Shaw, Ralph G Brindis, Charles R McKay, Lloyd W Klein, Ronald J Krone, Kalon K L Ho, John S Rumsfeld, Sidney C Smith, William S Weintraub.   

Abstract

An American College of Cardiology (ACC)/American Heart Association (AHA) task force on practice guidelines in 2001 published evidence-based recommendations for performing percutaneous coronary interventions (PCIs). These guidelines grouped the indications for PCI into 4 classes (I, IIa, IIb, and III) based on analyses of risks and benefits. In a previous study, we found that clinical success and in-hospital adverse events varied by indications class. However, no adjustment for risk was used in those comparisons. The ACC/National Cardiovascular Data Registry (ACC-NCDR) previously developed a risk-adjustment model for the adverse event of in-hospital PCI mortality. We investigated how the 14 individual risk factors in the ACC-NCDR PCI mortality model might differ across the 4 indications classes and whether estimated mortality for each class approximated the observed mortality for that class. We analyzed the ACC-NCDR PCI database for January 1, 2001 to December 31, 2004. We excluded procedures performed for treatment of acute ST-segment elevation myocardial infarction; all others were included, yielding 559,273 procedures for analysis. An algorithm derived from the 2001 guidelines was used to assign procedures to an indications class. Increasing frequencies of risk components were observed across classes I, IIa, IIb, and III. Expected mortalities for each class calculated by the risk-adjustment model were close to observed values (expected 0.52%, 0.59%, 1.72%, and 1.96%, respectively; observed 0.49%, 0.63%, 1.88%, and 1.60%, respectively). In conclusion, the ACC-NCDR risk-adjusted mortality model can be linked to the ACC/AHA PCI guidelines, and together these produce mortality risk estimates by indications classes that are close to actual observed values. With further refinement, these methods should be able to be used as powerful analytic tools for quality assurance and appropriateness purposes.

Entities:  

Mesh:

Year:  2006        PMID: 17223417     DOI: 10.1016/j.amjcard.2006.07.083

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  9 in total

1.  Contemporary incidence, predictors, and outcomes of acute kidney injury in patients undergoing percutaneous coronary interventions: insights from the NCDR Cath-PCI registry.

Authors:  Thomas T Tsai; Uptal D Patel; Tara I Chang; Kevin F Kennedy; Frederick A Masoudi; Michael E Matheny; Mikhail Kosiborod; Amit P Amin; John C Messenger; John S Rumsfeld; John A Spertus
Journal:  JACC Cardiovasc Interv       Date:  2014-01       Impact factor: 11.195

2.  Real-world use of intravascular ultrasound in Japan: a report from contemporary multicenter PCI registry.

Authors:  Toshiki Kuno; Yohei Numasawa; Mitsuaki Sawano; Takayuki Abe; Ikuko Ueda; Masaki Kodaira; Masahiro Suzuki; Shigetaka Noma; Iwao Nakamura; Koji Negishi; Shiro Ishikawa; Keiichi Fukuda; Shun Kohsaka
Journal:  Heart Vessels       Date:  2019-05-25       Impact factor: 2.037

3.  Sudden death after normal coronary angiography and possible causes.

Authors:  Suleyman Ercan; Mehmet Kaplan; Kazim Aykent; Vedat Davutoglu
Journal:  BMJ Case Rep       Date:  2013-02-15

4.  Acute adverse drug reactions following cardiac catheterization: evidence-based guidance for providers and systems.

Authors:  Spencer W Trooboff; Alexander Iribarne
Journal:  J Thorac Dis       Date:  2019-07       Impact factor: 2.895

5.  Impact of coronary dominance on in-hospital outcomes after percutaneous coronary intervention in patients with acute coronary syndrome.

Authors:  Toshiki Kuno; Yohei Numasawa; Hiroaki Miyata; Toshiyuki Takahashi; Koichiro Sueyoshi; Takahiro Ohki; Koji Negishi; Akio Kawamura; Shun Kohsaka; Keiichi Fukuda
Journal:  PLoS One       Date:  2013-08-26       Impact factor: 3.240

6.  High-sensitive troponin T assay for the diagnosis of acute myocardial infarction: an economic evaluation.

Authors:  Anil Vaidya; Johan L Severens; Brenda W C Bongaerts; Kitty B J M Cleutjens; Patty J Nelemans; Leonard Hofstra; Marja van Dieijen-Visser; Erik A L Biessen
Journal:  BMC Cardiovasc Disord       Date:  2014-06-13       Impact factor: 2.298

7.  Effects of body habitus on contrast-induced acute kidney injury after percutaneous coronary intervention.

Authors:  Toshiki Kuno; Yohei Numasawa; Mitsuaki Sawano; Toshiomi Katsuki; Masaki Kodaira; Ikuko Ueda; Masahiro Suzuki; Shigetaka Noma; Koji Negishi; Shiro Ishikawa; Hiroaki Miyata; Keiichi Fukuda; Shun Kohsaka
Journal:  PLoS One       Date:  2018-09-13       Impact factor: 3.240

8.  Performance of in-hospital mortality prediction models for acute hospitalization: hospital standardized mortality ratio in Japan.

Authors:  Hiroaki Miyata; Hideki Hashimoto; Hiromasa Horiguchi; Shinya Matsuda; Noboru Motomura; Shinichi Takamoto
Journal:  BMC Health Serv Res       Date:  2008-11-07       Impact factor: 2.655

Review 9.  Risks and complications of coronary angiography: a comprehensive review.

Authors:  Morteza Tavakol; Salman Ashraf; Sorin J Brener
Journal:  Glob J Health Sci       Date:  2012-01-01
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.